Clinical and microbiological characteristics of tigecycline non-susceptible Klebsiella pneumoniae bacteremia in Taiwan

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Lin, Yi Tsung ^a,b   Wang, Fu Der ^a,b   Chan, Yu Jiun ^a,b   Fu, Yung Chieh ^a   Fung, Chang Phone ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Antimicrobial resistance; Bacteremia; Clinical characteristics; Klebsiella pneumoniae; Tigecycline

Indexed keywords

AMIKACIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CARBAPENEMASE; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; MINOCYCLINE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENE; CARBAPENEMASE GENE; CLINICAL ARTICLE; DHA 1 GENE; EXTENDED SPECTRUM BETA LACTAMASE GENE; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN; ANALOGS AND DERIVATIVES; ANTIBIOTIC RESISTANCE; CROSS INFECTION; GENETICS; ISOLATION AND PURIFICATION; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINOCYCLINE; RETROSPECTIVE STUDIES; TAIWAN;

EID: 84891348941     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-1     Document Type: Article

References (29)

1. Meatherall BL, Gregson D, Ross T, Pitout JDD, Laupland KB. Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia. Am J Med 2009, 122(9):866-873. 10.1016/j.amjmed.2009.03.034, 19699383.
2. Podschun R, Ullmann U. Klebsiella spp. As nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998, 11:589-603. 88898, 9767057.
3. Lin YT, Chen TL, Siu L, Hsu SF, Fung CP. Clinical and microbiological characteristics of community-acquired thoracic empyema or complicated parapneumonic effusion caused by Klebsiella pneumoniae in Taiwan. Eur J Clin Microbiol Infect Dis 2010, 29:1003-10. 10.1007/s10096-010-0961-8, 20505967.
4. Lin YT, Jeng YY, Chen TL, Fung CP. Bacteremic community-acquired pneumonia due to Klebsiella pneumoniae: clinical and microbiological characteristics in Taiwan, 2001-2008. BMC Infect Dis 2010, 10:307. 10.1186/1471-2334-10-307, 2987304, 20973971.
5. Tseng CP, Wu HS, Wu TH, Lin YT, Fung CP. Clinical characteristics and outcome of patients with community-onset Klebsiella pneumoniae bacteremia requiring intensive care. J Microbiol Immunol Infect 2013, 46:217-23. 10.1016/j.jmii.2012.06.001, 22832028.
6. Wu HS, Wang FD, Tseng CP, Wu TH, Lin YT, Fung CP. Characteristics of healthcare-associated and community-acquired Klebsiella pneumoniae bacteremia in Taiwan. J Infect 2012, 64:162-8. 10.1016/j.jinf.2011.11.005, 22101080.
7. Lin YT, Wang FD, Wu PF, Fung CP. Klebsiella pneumoniae liver abscess in diabetic patients: association of glycemic control with the clinical characteristics. BMC Infect Dis 2013, 13:56. 10.1186/1471-2334-13-56, 3568401, 23363608.
8. Keynan Y, Rubinstein E. The changing face of Klebsiella pneumoniae infections in the community. Int J Antimicrob Agents 2007, 30:385-9. 10.1016/j.ijantimicag.2007.06.019, 17716872.
9. Livermore DM. Has the era of untreatable infections arrived?. J Antimicrob Chemother 2009, (1):i29-36.
10. Sun Y, Cai Y, Liu X, Bai N, Liang B, Wang R. The emergence of clinical resistance to tigecycline. Int J Antimicrob Agents 2013, 41:110-6. 10.1016/j.ijantimicag.2012.09.005, 23127485.
11. Rodríguez-Avial C, Rodríguez-Avial I, Merino P, Picazo JJ. Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient. Clin Microbiol Infect 2012, 18:61-6. 10.1111/j.1469-0691.2011.03482.x, 21722259.
12. Daphnis E, Neonakis I, Stylianou K, Maraki S. First case of resistance to tigecycline by Klebsiella pneumoniae in a European University Hospital. Indian J Med Microbiol 2011, 29(1):78-9. 10.4103/0255-0857.76535, 21304206.
13. Tsai HY, Liao CH, Cheng A, Liu CY, Huang YT, Sheng WH, Hsueh PR. Emergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenem-resistant Escherichia coli. J Infect 2012, 65:584-6. 10.1016/j.jinf.2012.09.007, 23000236.
14. Roy S, Datta S, Viswanathan R, Singh AK, Basu S. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility. J Antimicrob Chemother 2013, 68:1036-42. 10.1093/jac/dks535, 23335112.
15. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement 2012, Wayne, PA: CLSI: Document M100-S22, Clinical and Laboratory Standards Institute.
16. Pillar CM, Draghi DC, Dowzicky MJ, Sahm DF. In vitro activity of tigecycline against Gram-positive and Gram-negative pathogens as evaluated by broth microdilution and Etest. J Clin Microbiol 2008, 46:2862-7. 10.1128/JCM.00637-08, 2546738, 18596149.
17. Ma L, Lu PL, Siu LK, Hsieh MH. Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002-2009. J Med Microbiol 2013, 62:101-7. 10.1099/jmm.0.050492-0, 23002067.
18. Fang CT, Lai SY, Yi WC, Hsueh PR, Liu KL, Chang SC. Klebsiella pneumoniae genotype K1: an emerging pathogen that causes septic ocular or central nervous system complications from pyogenic liver abscess. Clin Infect Dis 2007, 45:284-93. 10.1086/519262, 17599305.
19. Turton JF, Perry C, Elgohari S, Hampton CV. PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets. J Med Microbiol 2010, 59:541-7. 10.1099/jmm.0.015198-0, 20110386.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-83. 10.1016/0021-9681(87)90171-8, 3558716.
21. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, Gal-Mor O, Maor Y, Rahav G. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012, 18:54-60.
22. Qureshi ZA, Paterson DL, Peleg AY, Adams-Haduch JM, Shutt KA, Pakstis DL, Sordillo E, Polsky B, Sandkovsky G, Bhussar MK, Doi Y. Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases. Clin Microbiol Infect 2012, 18:887-93. 10.1111/j.1469-0691.2011.03658.x, 3252485, 21951551.
23. Huang TD, Berhin C, Bogaerts P, Glupczynski Y. In vitro susceptibility of multidrug-resistant Enterobacteriaceae clinical isolates to tigecycline. J Antimicrob Chemother 2012, 67:2696-9. 10.1093/jac/dks288, 22833638.
24. Zarkotou O, Pournaras S, Altouvas G, Pitiriga V, Tziraki M, Mamali V, Themeli-Digalaki K, Tsakris A. Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant Gram-negative pathogens. J Clin Microbiol 2012, 50:3747-50. 10.1128/JCM.02037-12, 3486197, 22933593.
25. Bolmström A, Karlsson T, Engelhardt A, Ho P, Petersen PJ, Bradford PA, Jones CH. Validation and reproducibility assessment of tigecycline MIC determinations by Etest. J Clin Microbiol 2007, 45:2474-9. 10.1128/JCM.00089-07, 1951261, 17522277.
26. Qureshi ZA, Paterson DL, Potoski BA, Kilayko MC, Sandovsky G, Sordillo E, Polsky B, Adams-Haduch JM, Doi Y. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012, 56:2108-13. 10.1128/AAC.06268-11, 3318350, 22252816.
27. Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, Losito AR, Tedeschi S, Cauda R, Bassetti M. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012, 55:943-50. 10.1093/cid/cis588, 22752516.
28. Capone A, Giannella M, Fortini D, Giordano A, Meledandri M, Ballardini M, Venditti M, Bordi E, Capozzi D, Balice MP, Tarasi A, Parisi G, Lappa A, Carattoli A, Petrosillo N, SEERBIO-GRAB network High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect 2013, 19:E23-E30. 10.1111/1469-0691.12070, 23137235, SEERBIO-GRAB network.
29. Nigo M, Cevallos CS, Woods K, Flores VM, Francis G, Perlman DC, Revuelta M, Mildvan D, Waldron M, Gomez T, Koshy S, Jodlowski T, Riley W, Ruhe JJ. Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother 2013, 57:5743-6. 10.1128/AAC.00827-13, 23979745.